Quality of life related to recombinant TSH treatment compared to no treatment related to iodine uptake, in patient with thyroid cancer. A double blinded, randomized crossover study. Dathyrca I.

Trial Profile

Quality of life related to recombinant TSH treatment compared to no treatment related to iodine uptake, in patient with thyroid cancer. A double blinded, randomized crossover study. Dathyrca I.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Apr 2014

At a glance

  • Drugs Thyrotropin alfa (Primary) ; Liothyronine
  • Indications Thyroid cancer
  • Focus Diagnostic use
  • Acronyms Dathyrca I
  • Most Recent Events

    • 02 Apr 2014 Status changed from discontinued to completed.
    • 03 Mar 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 23 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top